Merck Targets Experts In Next Fosamax Bellwether

Law360, New York (October 12, 2010, 6:45 PM EDT) -- Fresh off a victory in another case over Fosamax, lawyers for plaintiff Judith Graves on Tuesday battled Merck & Co. Inc.'s efforts to prevent her physicians from testifying at a possible trial that the osteoporosis drug caused a bone-rotting condition in her jaw.

Attorney Timothy M. O’Brien, of Levin Papantonio Thomas Mitchell Echsner Rafferty & Proctor PA, who also handled the winning case for plaintiff Shirley Boles, told a judge in the U.S. District Court for the Southern District of New York that the doctors’ testimony...
To view the full article, register now.

Related

Sections

Case Information

Case Title

Graves v. Merck & Co., Inc.


Case Number

1:06-cv-05513

Court

New York Southern

Nature of Suit

Personal Inj. Prod. Liability

Judge

John F. Keenan

Date Filed

July 21, 2006

Law Firms

Companies

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.